Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMXGE3O)

Drug Name	SAR408701 DMXGE3O
Drug Type	Antibody drug conjugate

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 3	[1]
------------------------------------------------------------------------------------

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1/2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04154956) SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients (CARMEN-LC03). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02187848) Evaluation of SAR408701 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.